Vicarious Surgical (RBOT) H.C. Wainwright 27th Annual Global Investment Conference summary

Company vision and market opportunity

• Focuses on developing a minimally invasive robotic surgical system to address limitations of current platforms, especially in adaptability and ease of use.

• Targets procedures beyond prostatectomy, where current robotic adoption is low due to system rigidity and limited access.

• Initial clinical focus is ventral hernia repair, chosen to showcase unique intra-abdominal access and visualization capabilities.

• Sees a large addressable market, with 82% of 5.5 million annual U.S. procedures still performed non-robotically.

• Aims to capture even a small share of this untapped market, differentiating from competitors by not directly targeting their existing market share.

Technology differentiation

• System features decoupled actuators, intra-abdominal motion, and nine degrees of freedom for enhanced dexterity.

• Offers 360-degree visualization, a self-cleaning camera, and full anatomical reach, especially in challenging upper abdomen areas.

• Single-port entry with two internal arms reduces external crowding and incision count, improving flexibility and access.

• Protected by patents and future plans for AI and automation integration.

Development progress and milestones

• Transitioned from engineering project to company with robust quality management and traceability.

• Achieved first controlled system build in April, followed by a second, more efficient build in August.

• Currently at 63% completion of functional and safety requirements, aiming for 100% by mid-next year.

• Design lock targeted for end of next year, after which regulatory verification and validation will begin.